0I8C Stock Overview
Engages in the manufacture and sale of ingredients for cosmetic industry in Norway. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Aqua Bio Technology ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 2.58 |
| 52 Week High | NOK 5.68 |
| 52 Week Low | NOK 2.00 |
| Beta | 0 |
| 1 Month Change | 29.00% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -84.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0I8C | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 0.4% |
| 1Y | n/a | -23.2% | 3.9% |
Return vs Industry: Insufficient data to determine how 0I8C performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how 0I8C performed against the UK Market.
Price Volatility
| 0I8C volatility | |
|---|---|
| 0I8C Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 6.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0I8C's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0I8C's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Fredrik Henriksen | aquabiotechnology.com |
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics.
Aqua Bio Technology ASA Fundamentals Summary
| 0I8C fundamental statistics | |
|---|---|
| Market cap | NOK 228.56m |
| Earnings (TTM) | -NOK 1.50m |
| Revenue (TTM) | NOK 13.82m |
0.0x
P/S Ratio0.0x
P/E RatioIs 0I8C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0I8C income statement (TTM) | |
|---|---|
| Revenue | NOK 13.82m |
| Cost of Revenue | NOK 4.50m |
| Gross Profit | NOK 9.32m |
| Other Expenses | NOK 10.82m |
| Earnings | -NOK 1.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 0I8C perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 10:57 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aqua Bio Technology ASA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tomas Skeivys | Norne Securities AS |